The DOI matches its Crossref record; 126 of the 130 references it cites were found in a registry or an index.
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Abstract
It is well known that Alzheimer's disease (AD) is closely related to diabetes mellitus (DM), and AD is also regarded as Type 3 diabetes (T3D). However, the exact link between AD and DM is still unclear. Recently, more and more evidence has shown that glycogen synthase kinase-3β (GSK-3β) may be the potential link between DM and AD. In DM, GSK-3β is the crucial enzyme of glycogen synthesis, which plays a key role in regulating blood glucose. More importantly, GSK-3β is one of the key factors leading to insulin deficiency and insulin resistance, and insulin resistance is an important hallmark of the occurrence and development of DM. In AD, GSK-3β plays an important role in hyperphosphorylation of microtubule-associated protein tau (tau), which is one of the pathological features in AD. GSK-3β is one of the important kinases of tau phosphorylation and is involved in the insulin/phosphoinositide 3-kinase/protein kinase B (insulin/PI3K/Akt) signaling pathway. Dysfunction of the insulin/PI3K/Akt signaling pathway, which regulates glucose metabolism in the brain, can lead to tau hyperphosphorylation in the brain of AD patents. Additionally, insulin resistance in DM may cause β-amyloid (Aβ) deposition, which will be cleared by tau, but excessive phosphorylation of tau will further aggravate the neurotoxicity; then damage the brain and affect the cognitive function. GSK-3β is considered as a common kinase in insulin signaling transduction and tau protein phosphorylation, so we have reasons to believe that GSK-3β is a potential link between DM and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impaired insulin secretion is multifactorial, the exact mechanism is still unclear, but commonly develops from glucose toxicity, lipid toxicity, immunoinflammatory response, and oxidative stress, leading to the dysfunction of islet β cells (72).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [72]
In the citing paper
“When the insulin signaling pathway fails, the expression of GSK3β improves, which reduces the insulin sensitivity and increases the levels of blood glucose, thus subsequently leading to T2D (72, 96, 97).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [72]
In the citing paper
“In addition, the impairment of insulin signaling induces an increased activation of GSK-3β, which phosphorylates Tau, hence leading to Tau hyperphosphorylation (Hong and Lee, 1997; Planel et al., 2007; Zhang et al., 2018; Wei et al., 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Zhang et al., 2018
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Robertson, R. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400019200 · Cited by 1,078
Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease
KIDD, M. (1963) · Nature · doi:10.1038/197192b0 · Cited by 1,012
Flagged first, then by citations
4 of the 130 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–298 of 298
Moreira, N. C. D. S., Piassi, L. D. O., Lima, J. E. B. D. F., Passos, G. A. S., & Sakamoto‐Hojo, E. T. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352194 · Cited by 5
Endogenous micropeptides as potential diagnostic biomarkers and therapeutic drugs
Zhong, A., Li, S., Zhang, J., Zhao, J., & Yao, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1545575 · Cited by 6
Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker
Rebolledo-Pérez, L., Hernández‐Bello, J., Martínez-Ramos, A., Castañeda‐Arellano, R., Fernández-Quezada, D., Sandoval-García, F., & Aguilar-García, I. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157638 · Cited by 6
DURAN, R., PANCUR, S., & Bahadorı, F. (2022) · Bezmialem Science · doi:10.14235/bas.galenos.2020.4491 · Cited by 5
Sleeve gastrectomy attenuated diabetes-related cognitive decline in diabetic rats
Ding, H., Liu, C., Zhang, S., Li, B., Xu, Q., Shi, B., Li, S., Dong, S., Ma, X., Zhang, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1015819 · Cited by 5
Self-citationLi, C., Qian, H., Feng, L., & Li, M. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-240053 · Cited by 6
GSK‑3β mediates the effects of HNF‑1β overexpression in ovarian clear cell carcinoma
Kawahara, N., Mizutani, A., Matsubara, S., Takeda, Y., & Kobayashi, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9250 · Cited by 5
GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis
Luo, X., Shi, X., Sun, Z., Xiao, J., Song, H., Guo, L., & Xu, X. Y. (2020) · BioMed Research International · doi:10.1155/2020/1454396 · Cited by 5
Hao, S., Chen, X., Zhang, D., Song, W., Zhou, Y., Yuan, Z., Liu, Z., Yue, X., & Yuan, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13723 · Cited by 4
Yoshida, T., Mori, T., Shimizu, H., Tachibana, A., Yoshino, Y., Ochi, S., Yamazaki, K., Ozaki, Y., Kawabe, K., Horiuchi, F., et al. (2023) · Psychogeriatrics · doi:10.1111/psyg.13012 · Cited by 4
Zhou, F., Wang, Z., Xiong, K., Zhang, M., Wang, Q., Wang, Y., & Li, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28551 · Cited by 4
Gu, H., Zhang, Y., Sun, J., Liu, L., & Liu, Z. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2445181 · Cited by 4
Self-citationPei, M., Qian, A., Cao, L., Wang, Z., Lu, Y., Yan, C., & Liang, T. (2025) · New Journal of Chemistry · doi:10.1039/d4nj01951b · Cited by 5
Hyung, W. W. S., Lee, S. G., Kim, K. T., & Kim, H. S. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001271 · Cited by 4
Wang, J., Wang, D., Liu, F., Ji, Y., Peng, X., & Li, G. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109053 · Cited by 3
Altındağ, F., Bayır, M. H., Alhalboosi, J. K. I., & Yıldızhan, K. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115556 · Cited by 3
High-fat Western diet induces retinal and metabolic alterations in APOE3 and APOE4 knock-in mice
Abhyankar, S. D., Luo, Q., Hartman, G. D., Mahajan, N. S., Corson, T. W., Oblak, A. L., Lamb, B. T., & Bhatwadekar, A. D. (2026) · Scientific Reports · doi:10.1038/s41598-025-34776-9 · Cited by 3
Rational design of k-casein peptides to modulate GSK-3B dynamics for Alzheimer’s therapy
Moghaddam, N., Ramazani, A., & Zarei, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-42103-z · Cited by 3
Wei, W., Xu, P., Li, L., Mao, H., Li, N., Wang, X., Wang, L., Xu, Z., & Zhao, S. W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1386773 · Cited by 3
Sturaro, G., Tasso, A., Menilli, L., Liddo, R. D., Miolo, G., & Conconi, M. T. (2021) · Biomolecules · doi:10.3390/biom11020158 · Cited by 3
Das‐Earl, P., Schreihofer, D. A., Sumien, N., & Schreihofer, A. M. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00409.2023 · Cited by 3
Elucidating the potential of natural bioactive compounds in neuroprotection
Debnath, A., Majumder, R., Singh, M. K., Saha, R. P., & Das, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00032-2 · Cited by 3
Hydrogen sulfide in the brain as a silent neuroprotector in Alzheimer’s disease
Layal, H., Rajbongshi, J., Kumar, R., Pandey, S., Mishra, R., & Yadav, P. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.057 · Cited by 4
Sakr, H. I., Amen, M. A., Rashed, L. A., Khowailed, A. A., Sayed, H. A., Motawee, M. E. E., Sakr, H., & Khalifa, M. M. (2020) · Archives of Medical Science · doi:10.5114/aoms.2020.99023 · Cited by 3
Deep Sea Water Alleviates Tau Phosphorylation and Cognitive Impairment via PI3K/Akt/GSK-3β Pathway
He, S., Peng, W.-B., Fu, X., Zhou, H., & Wang, Z. (2022) · Marine Biotechnology · doi:10.1007/s10126-021-10087-8 · Cited by 3
Dinakar, S., Gurubarath, M., & Dhananjayan, K. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2074143 · Cited by 3
Maschio, D. A., Hernandes, L. H. P., Alvares, L. E., Marques‐Souza, H., & Collares‐Buzato, C. B. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.047 · Cited by 2
Kumar, H., Datusalia, A. K., Kumar, A., & Khatik, G. L. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2472406 · Cited by 4
Neurodegenerative Disease: Nanotechnology to Rescue
Doke, R. R., Lamkhade, G., Manchare, B. R., & Vinchurkar, K. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_19 · Cited by 3
He, Z., Diao, J., Hamel, F. G., & Duan, B. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.02.023 · Cited by 2
Multidimensional mechanisms of quercetin in diabetic kidney disease
Gong, Z., Che, Q., Wang, C., Liu, B., Hu, M., Zhang, H. P., Liang, N., Li, H., Zhao, G., Yan, L., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1705601 · Cited by 2
Liu, J., Peng, F., Li, P., Yao, C., Jin, S., Wu, G., Zhang, T., Liang, Q., Wang, X., & Du, X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03525-3 · Cited by 2
Alqahtani, S. M., Khired, Z. A., Dawood, A. F., Alshahrani, M. Y., AlZamil, N. M., Al‐Ani, B., & Al-Hashem, F. H. (2023) · International Journal of Pharmacology · doi:10.3923/ijp.2023.305.312 · Cited by 2
Parekh, J., Shende, H., Kumar, A., Tuli, H. S., & Kaur, G. (2024) · Current Pharmacology Reports · doi:10.1007/s40495-024-00354-2 · Cited by 2
Nutrition and neurodegenerative diseases: Alzheimer's disease and others
Bianchi, V. E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91747-6.00013-5 · Cited by 2
Yen, S., Wang, Y., & Liao, L. (2024) · APL Bioengineering · doi:10.1063/5.0193267 · Cited by 3
Mitochondrial dysfunction in metabolic disorders
Advani, D., Sharma, S., Tripathi, R. S., Gupta, R. V., Jaiswal, A., Ambasta, R. K., & Kumar, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00015-2 · Cited by 3
Arfeen, M., Alharbi, S. S., & Alharbi, A. N. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00232 · Cited by 2
Chu, S., Yinan, Z., Li, H.-L., Hengxia, Z., Liu, D., & Xuemei, L. (2019) · Open Chemistry · doi:10.1515/chem-2019-0130 · Cited by 1
Liu, Y., He, B., Du, K., Zheng, J., Ke, D., Mo, W., Li, Y., Jiang, T., Xiong, R., Sun, F., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240455 · Cited by 1
Self-citationMechanism for the association between diabetes or anti‐diabetic medications and incident dementia
Araki, A. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70066 · Cited by 1
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273370166250610152453 · Cited by 1
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Liang, M., et al. (2024) · eLife · doi:10.7554/elife.99462.3 · Cited by 4
Self-citationSuo, Y., Fu, Y., Wang, C., Wu, Y., & Tian, P. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111562 · Cited by 2
de Ceglia, M., Botticelli, L., Bonaventura, E. M. D., Fuentes, A. V., Bonaventura, M. V. M. D., de Fonseca, F. R., & Cifani, C. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108005 · Cited by 1
Potential of Benfotiamine in the treatment of neuropsychological disorders
Motamedzadeh, A., Karimzad, Y., Ferdosi, F., Nabavizadeh, F., Rahmati‐Dehkordi, F., Dadgostar, E., Aschner, M., Validad, A., Kazemi, B., & Tamtaji, O. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11198-4 · Cited by 1
Kawahara, N., Kuniyasu, H., Mori, S., Kishi, S., Sugimoto, S., Maehana, T., Yamanaka, S., Kawaguchi, R., & Kimura, F. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08243-2 · Cited by 1
Mujtaba, M., Shafiq, M. I., Ismail, H., Hameed, M., Al-Otaibi, J. S., & Khan, H. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100201 · Cited by 1
Chronobiology and Neurodegeneration: The Role of Melatonin in Alzheimer's Disease
Vaja, R., Vohra, M., Ramachandran, A. V., & Baxi, D. B. (2025) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2025.100001 · Cited by 1
Elsayed, A., Zakaria, A., Fayed, A.-H. A., Khalifa, E., Khalifa, N. E., & Saad, . M. (2026) · Microscopy and Microanalysis · doi:10.1093/mam/ozag003 · Cited by 1
TREM2 as a possible link between Alzheimer's disease and diabetes mellitus
Chen, W., Huang, N., Huang, W., Wang, M., Luo, Y., & Huang, J. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115739 · Cited by 3
Self-citationIs Alzhezimer’s disease a New Type Diabetes? Crosstalk between two serious disorders: review
Dobosz, M., Rudziński, G., Chilimoniuk, Z., Więsyk, P. J., Kusak, N., & Chałupnik, A. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.13.03.017 · Cited by 2
Neuroprotective Effects of Gypenosides and Their Underlying Mechanisms
Zhou, C., Chen, J., & Wang, X. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010208 · Cited by 1
GRg1 Ameliorates Insulin Resistance Through Activation of the PI3K/AKT/GSK-3β Pathway in HepG2 Cells
Shen, X., Jin, Y., Chen, Y., & Yang, H. (2023) · Pharmacognosy Magazine · doi:10.1177/09731296231198284 · Cited by 1
A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs
Feng, Y. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128310724240730072626 · Cited by 1
Mirdad, T. M., Al‐Ani, B., Aseeri, F. F., Kamar, S. S., Mirdad, R. T., Al-Gilban, H. M., Haidara, M. A., Abbas, A. M., & Dawood, A. F. (2022) · International Journal of Morphology · doi:10.4067/s0717-95022022000100084 · Cited by 1
Putri, S. R. D., Bella, I., Khaerunnisa, S., Susanti, N., & Mustika, A. (2023) · Current Internal Medicine Research and Practice Surabaya Journal · doi:10.20473/cimrj.v4i1.42288 · Cited by 1
Prevailing Antagonistic Risks in Pleiotropic Associations with Alzheimer’s Disease and Diabetes
Kulminski, A. M., Feng, F., Loiko, E., Nazarian, A., Loika, Y., & Culminskaya, I. V. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230397 · Cited by 2
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Jiang, P., et al. (2024) · eLife · doi:10.7554/elife.99462.1 · Cited by 1
Self-citationCorrection to “Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease”
Li, Z., Zhang, Z., & Yu, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00926 · Cited by 1
Xu, W., Jian-cong, L., Chen, M., Zhang, C., & Li, Y. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.05.18
The Effect of Continuous Aerobic Exercise on Neurodegeneration in Diabetic Rats
Omidi, M., Ghanbarzadeh, M., Nikbakht, M., Habibi, A., & Rangbar, R. (2018) · Annals of Military and Health Sciences Research · doi:10.5812/amh.85194
Diabetes Mellitus and Alzheimer's Disease: Neuromorphology оf Cognitive Impairment
Mykhaylichenko, T., & Volos, L. I. (2020) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs05.02.070
Sánchez‐Sarasúa, S. (2021) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · doi:10.6035/14112.2021.368012
Suitability of Cherokee Reservoir and the upper Holston River for sauger and walleye
Edrington, C. J., Starnes, L. B., & Hackney, P. A. (1979) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Mao, G., Tang, J., Liao, T., Shi, X., Dong, F., Feng, W., Chen, Y., Zhao, T., Wu, X., & Yang, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1552684/v1
Mitogenic and Metabolic signals regulate mTOR complex 1 function to control GSK3β nuclear program
Bautista, S. J. (2021) · doi:10.32920/ryerson.14654061.v1 · Cited by 1
Mao, G., Tang, J., Liao, T., Shi, X., Dong, F., Feng, W., Chen, Y., Zhao, T., Wu, X., & Yang, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1552684/v2
Zhang, M., Wang, Y., Chen, X., Guan, X., Dai, L., Bai, Y., & Guo, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2299293/v1
Genetic modulators of neurodegenerative diseases and their amelioration by natural products
Hameed, R., Naseer, A., Toppo, P., Akbar, M., Yadav, S., & Nazir, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00019-3
Loreto, J. S., Ferreira, S. A., de Almeida, P., da Rocha, J. B. T., & Barbosa, N. V. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03598-z · Cited by 1
Zhang, M., Wang, Y., Guan, X., Chen, X., & Guo, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3848505/v1
Asociación Mexicana de Neuropsicología. 25 años de práctica clínica e investigación
Hernández-Galván, A., Téllez-Alanís, B., & Rodríguez, M. (2023) · Universidad Autónoma del Estado de Morelos eBooks · doi:10.30973/2023/amn25 · Cited by 1
Qi, W., Long, Y., Li, Z., Zhao, Z., Shi, J., Xie, W., Wang, L., Tan, Y., Zhou, T., Liang, M., et al. (2025) · eLife · doi:10.7554/elife.99462.2
Self-citationLong-term Dietary Fat Intervention Affects Retinal Health in APOE MicePreprint
Abhyankar, S. D., Luo, Q., Hartman, G. D., Mahajan, N. S., Corson, T. W., Oblak, A. L., Lamb, B. T., & Bhatwadekar, A. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.30.667671
Yadav, Y., Sharma, M., & Dey, C. S. (2024) · Figshare · doi:10.6084/m9.figshare.26584101
Iheagwam, F. N., Ayeni, T. O., & Oduselu, G. O. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100232
Cheng, J., Zheng, T., Lin, T.-Y., Zhang, Z., Zheng, K., Li, X., Wu, X., Zhongquan, L. I., Wu, X., & Liu, B. (2026) · Chinese Journal of Analytical Chemistry · doi:10.1016/j.cjac.2026.100713
Roy, M. K., Mukherjee, A., & Chatterjee, R. (2026) · Bengal Physician Journal · doi:10.5005/jp-journals-10070-8127
A literature review on the relationship between diabetes and dementia
Chen, C., & Liao, D.-M. (2026) · 童綜合醫學雜誌 · doi:10.4103/etmj.etmj-d-25-00032
Karmakar, A., Roycowdhury, P., Sengupta, P., & Mukhopadhyay, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.02.007
Barraza, J. D. G., Conde-Cardona, G., Contreras‐Puentes, N., Rodríguez, R. E., Torres, K. V., Rivera, S. T., Gazabon, K. Z., & Peñaloza, E. O. (2026) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2025-5245
Vashisht, K., Kumar, H., Ankalgi, A. D., Ashawat, M. S., Baldi, A., & Kushawaha, S. K. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02225-2
Hamel, L., Pereira, S. X. E. R. L., Yang, Z., Garrido, A. N., Agarwal, S. M., Lam, T. K. T., & Hahn, M. K. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10034-9 · Cited by 1
The iron-energy metabolism axis in Alzheimer’s pathogenesis: from mechanisms to interventions
Zou, Z., Chen, J., Li, J., & Zou, Z. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03034-w · Cited by 2
The mechanism of Huanglian-Wendan decoction in treating PCOS-IR based on PI3K-AKT-GSK3 pathway
Wen, Y., Chang, H., Liu, L., Zhang, D., & Wang, M. (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102469
Yazi, S., Özen, B., Buldu, B., Yalçın, E., Karakose, O., Cakmak, O., Somunkiran, S., Yananlı, H. R., Sehirli, U. S., & Kirazlı, Ö. (2026) · Brain Structure and Function · doi:10.1007/s00429-026-03142-4
Kumar, S., Pandey, R. K., Singh, L., & Prajapati, A. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00806-2
Zhou, S., & Di, N. (2026) · RSC Advances · doi:10.1039/d6ra04796c
Self-citationTkemaladze, J. (2026) · Longevity Horizon · doi:10.65649/9347j1ap · Cited by 2
Zhang, S., Yu, S., Yang, D., Liu, Y., & Du, W. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115987
Li, Z., Liu, J., Chu, T., & Gao, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188135
Caloric restriction’s molecular pathways: Unlocking neuroprotection in neurodegenerative diseases
MITKARI, M., Pawar, A., Hulwale, A., Shelke, V., Vyavahare, S., Doke, R. R., & Singh, S. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100543
Fan, D., Zhai, W., Zhang, Q., Li, J., Wang, Y., & Sun, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261499707
BindingDB Entry 50019411: Glycogen synthase kinase-3: A potential target for diabetes.
BindingDB (2024) · UC San Diego · doi:10.7270/q2rn3d6s
BindingDB (2026) · UC San Diego · doi:10.7270/q2cz3d17
Metadata
- Authors
- Zhang, Y., Huang, N.-Q., Yan, F., Jin, H., Zhou, S.-Y., Shi, J.-S., & Jin, F.
- Affiliations
- Zunyi Medical University (CN)
- Corresponding author
- Jin, Hai
- Jin, Feng
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 339
- Pages
- 57-65
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2770586248
- Cited by
- 301
- References
- 130
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 45 · 2023: 48 · 2022: 42 · 2021: 38 · 2020: 37 · 2019: 14 · 2018: 10
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81660599, 81360311, 81460548)
- Postgraduate Education Foundation of Guizhou Province (KYJJ2017008)
- Zunyi Medical University Funds (2013F-686, F-738)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- diabetes mellitus, Alzheimer's disease, glycogen synthase kinase-3β, type 3 diabetes, insulin resistance, tau hyperphosphorylation, amyloid-beta deposition, glycogen synthesis, neurotoxicity
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Diabetes Mellitus, Humans, Insulin, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review